3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Neuroendocrine Tumors
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
22
Cisplatin
17
Surveys and Questionnaires
8
Radiotherapy
8
Carboplatin
8
Radiotherapy, Intensity-Modulated
7
Cetuximab
7
Paclitaxel
6
Nivolumab
6
Drug Therapy
6
Radiation
4
Fluorouracil
4
Taxes
3
Docetaxel
3
selpercatinib
2
dostarlimab
2
Yoga
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
Chemoradiotherapy
2
Blood Specimen Collection
2
ALX148
2
veliparib
1
tisotumab vedotin
1
tislelizumab
1
palbociclib
1
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Head and Neck Neoplasms
×
Radionuclide Imaging
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled